Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4976
Morningstar
MORN
$7.78B
| $2.25M | ﹤0.01% |
9,719
-53,823
| -85% | -$10.7M |
|
4977
Manitowoc
MTW
$746M
| $2.25M | ﹤0.01% |
169,148
+145,117
| +604% | +$1.55M |
|
4978
PUT
NeoGenomics
NEO
$2.05B
| $2.25M | ﹤0.01% |
41,800
+14,300
| +52% | +$646K |
|
4979
PUT
Root
ROOT
$797M
| $2.25M | ﹤0.01% |
+7,961
| New | +$2.63M |
|
4980
Invesco Large Cap Value ETF
PWV
$1.84B
| $2.25M | ﹤0.01% |
58,326
-16,425
| -22% | -$597K |
|
|
HTO
4981
H2O America
HTO
$2.65B
| $2.25M | ﹤0.01% |
32,415
+3,702
| +13% | +$241K |
|
4982
Avient
AVNT
$4.25B
| $2.25M | ﹤0.01% |
55,796
-83,096
| -60% | -$2.93M |
|
|
FLXN
4983
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.25M | ﹤0.01% |
194,694
-43,066
| -18% | -$500K |
|
4984
Puma Biotechnology
PBYI
$456M
| $2.24M | ﹤0.01% |
218,664
-195,007
| -47% | -$1.97M |
|
4985
PUT
Lakeland Industries
LAKE
$117M
| $2.24M | ﹤0.01% |
82,300
+22,900
| +39% | +$518K |
|
4986
CALL
MillerKnoll
MLKN
$1.62B
| $2.24M | ﹤0.01% |
66,300
-88,900
| -57% | -$3.1M |
|
4987
CALL
Alto Ingredients
ALTO
$327M
| $2.24M | ﹤0.01% |
412,600
+133,800
| +48% | +$929K |
|
4988
CALL
Palomar
PLMR
$3.37B
| $2.24M | ﹤0.01% |
25,200
+300
| +1% | +$25.2K |
|
|
MCFE
4989
CALL
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $2.24M | ﹤0.01% |
+134,100
| New | +$2.22M |
|
|
VSTO
4990
PUT
DELISTED
Vista Outdoor Inc.
VSTO
| $2.24M | ﹤0.01% |
94,200
+84,200
| +842% | +$1.8M |
|
4991
PUT
BioXcel Therapeutics
BTAI
$27.5M
| $2.24M | ﹤0.01% |
3,025
+1,262
| +72% | +$983K |
|
4992
CALL
Invesco CurrencyShares Australian Dollar Trust
FXA
$94.9M
| $2.24M | ﹤0.01% |
29,100
-14,700
| -34% | -$1.07M |
|
4993
CALL
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
| $2.23M | ﹤0.01% |
35,200
-34,600
| -50% | -$1.77M |
|
4994
CALL
Leggett & Platt
LEG
$1.32B
| $2.23M | ﹤0.01% |
50,400
+1,700
| +3% | +$72.9K |
|
|
FARO
4995
DELISTED
Faro Technologies
FARO
| $2.23M | ﹤0.01% |
31,577
+25,948
| +461% | +$1.72M |
|
4996
FT Vest US Equity Buffer ETF December
FDEC
$1.36B
| $2.23M | ﹤0.01% |
+72,771
| New | +$2.21M |
|
4997
PUT
Manhattan Associates
MANH
$11.5B
| $2.23M | ﹤0.01% |
21,200
+14,600
| +221% | +$1.44M |
|
4998
CALL
Plains All American Pipeline
PAA
$16.9B
| $2.23M | ﹤0.01% |
270,600
+4,100
| +2% | +$31.2K |
|
|
SILV
4999
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $2.23M | ﹤0.01% |
199,479
-201,999
| -50% | -$1.9M |
|
5000
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.7B
| $2.23M | ﹤0.01% |
54,640
+9,445
| +21% | +$366K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.